PubPharm - Specialised Information Services for Pharmacy

药学专业信息服务（SIS）的以药物为中心的搜索引擎及其创新服务将继续作为中央基础设施PubPharm。此外，所有服务都将集成到一个单一入口点，即新的综合平台www.pubpharm.de。大学图书馆与不伦瑞克工业大学信息系统研究所之间的合作产生了具有创新性质的生产性服务，得到了科学界的认可。这些服务，例如基于实体的上下文化和语义面化以及可视化实体网络（药物-目标-疾病网络），经常用于制药研究工作流程。信息技术研究以及信息基础设施与计算机科学之间的密切合作已被证明是前沿和模型构建。创新服务研究方面的新挑战将在第三个资助期内得到解决。例如，根据出版物和专家数据库中嵌入的知识预测药物和其他生物活性化合物之间的相互作用，对新发表的科学结果进行合理性检查，以及通过更好地解释基于人工智能的工具的输出来改善用户体验。此外，叙述性信息访问提供了一个精确的搜索利用变量在科学文献的论证结构。在此基础上，开发了智能工具，由科学界进行评估，并集成到PubPharm中。PubPharm的整体架构有一个重大的改进：所有的SIS服务，如新的特定主题存储库pharmRxiv、创新服务和社交媒体渠道的工作流程，都将嵌入到PubPharm中。此外，将建立可扩展的数字流程，用于索引、验证和语义丰富异构科学来源的元数据，如临床研究、专业数据库和研究数据。来自科学界的密集和系统的反馈保证了PubPharm以需求为基础，以用户为中心的定位。除了以药物为中心的搜索引擎，SIS服务的一个重要组成部分是为大学的制药科学家提供专业的数字期刊。开放获取活动、逆向数字化和长期保存以及研究数据管理咨询补充了SIS的投资组合。

The drug-centred search engine of the Specialised Information Service (SIS) for Pharmacy and its innovative services will be continued as the central infrastructure PubPharm. Furthermore, all services will be integrated into a Single Point of Entry, the new comprehensive platform www.pubpharm.de. The cooperation between the University Library and the Institute for Information Systems of the TU Braunschweig resulted in productive services with innovative character confirmed by the scientific community. These services, e.g. the entity-based contextualization and semantic faceting as well as the visualised entity networks (Drug-Target-Disease Networks), are frequently utilised in pharmaceutical research workflows. Information technology research and the close cooperation between information infrastructure and computer science have proven to be cutting-edge and model-building. New challenges in the research of innovative services will be addressed during the third funding period. Examples are the prediction of interactions between drugs and other bioactive compounds based on knowledge embedded in publications and specialist databases, the plausibility check of newly published scientific results and the improvement of user experience by better explaining the output of AI-based tools. Furthermore, narrative information access offers a precise search utilizing variables for argumentation structures in scientific literature. Based on this research, intelligent tools are developed, evaluated by the scientific community, and integrated into PubPharm. A major enhancement affects the overall architecture of PubPharm: all SIS services, such as the new subject-specific repository pharmRxiv, workflows for innovative services and social media channels, will be embedded in PubPharm. Furthermore, scalable digital processes will be established for indexing, validating and semantically enriching metadata of heterogeneous scientific sources, such as clinical studies, specialised databases and research data. Intensive and systematic feedback from the scientific community guarantees the requirements-based as well as the user-centric orientation of PubPharm. In addition to the drug-centred search engine, an important component of the SIS services is providing specialised digital journals to university-based pharmaceutical scientists. Open access activities, retro-digitization and long-term preservation as well as research data management consulting supplement the SIS portfolio.